SAGE Therapeutics Inc banner

SAGE Therapeutics Inc
NASDAQ:SAGE

Watchlist Manager
SAGE Therapeutics Inc Logo
SAGE Therapeutics Inc
NASDAQ:SAGE
Watchlist
Price: 8.68 USD Market Closed
Market Cap: $544.9m

During the last 3 months SAGE Therapeutics Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Aug 9, 2023 by Barrett Elizabeth , who bought 37.3k USD worth of SAGE shares.

Last Transactions:
Barrett Elizabeth
$+37.3k
Barrett Elizabeth
$+50.5k
Jonas Jeffrey M
$-347.1k
Greene Barry E
$+500k
Golumbeski George
$+251.6k
Greene Barry E
$+1m
Frates James M
$+99.7k
Starr Kevin P
$+1 000k
Greene Barry E
$+495.6k
Robichaud Albert
$+1.6m
Jonas Jeffrey M
$+481.5k
Frates James M
$-1.3m
Jonas Jeffrey M
$-33.8k
Jonas Jeffrey M
$-4.4m
Jonas Jeffrey M
$-1.4m
Jonas Jeffrey M
$-85.5k
Cloonan Michael
$-4.4m
Cook Anne Marie
$-2.5m
Frates James M
$-1.3m
Paul Steven M
$-482k
Paul Steven M
$-2.3m
Paul Steven M
$-144.9k
Iguchi Kimi
$-4m
Paul Steven M
$-112.7k
Paul Steven M
$-80.5k
Paul Steven M
$-32.4k
Paul Steven M
$-2m
Kanes Stephen
$-3.4m
Frates James M
$-1m
Frates James M
$-1.1m
Iguchi Kimi
$-14.1k
Iguchi Kimi
$-1.1m
View All Transactions

During the last 3 months SAGE Therapeutics Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Aug 9, 2023 by Barrett Elizabeth , who bought 37.3k USD worth of SAGE shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

SAGE Therapeutics Inc
Insider Trading Chart

SAGE Therapeutics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

SAGE Therapeutics Inc
Last Insider Transactions

Global
Insiders Monitor

SAGE Therapeutics Inc
Glance View

Market Cap
544.9m USD
Industry
Biotechnology

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel medicines. The company is headquartered in Cambridge, Massachusetts and currently employs 471 full-time employees. The company went IPO on 2014-07-18. The firm's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD) in adults. The company has a portfolio of other product candidates with a focus on modulating two central nervous system (CNS) receptor systems, GABA and NMDA. The company targets diseases and disorders of the brain with three focus areas: depression, neurology and neuropsychiatry. Its other advanced product candidate is zuranolone (SAGE-217), an oral compound being developed for certain affective disorders, including major depressive disorder (MDD) and PPD. Zuranolone is a neuroactive steroid that is a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors. The company has a portfolio of other compounds that target GABAA receptors, including SAGE-324.

SAGE Intrinsic Value
8.23 USD
Overvaluation 5%
Intrinsic Value
Price $8.68

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett